NASDAQ:VERO
Venus Concept Inc. Stock News
$0.621
-0.0133 (-2.10%)
At Close: May 17, 2024
Best Penny Stocks To Buy Now? 4 Insider Picks In November
10:05am, Wednesday, 23'rd Nov 2022
Penny stock picks from insiders in November 2022. The post Best Penny Stocks To Buy Now?
Activist Masters Capital Double Position in Venus Concept (VERO)
02:47am, Wednesday, 23'rd Nov 2022
Fintel reports that Masters Capital Management Llc has filed a 13D/A form with the SEC disclosing ownership of 22,999,173 shares of Venus Concept Inc (VERO).
Venus Concept Inc. (VERO) Q3 2022 Earnings Call Transcript
09:27pm, Thursday, 10'th Nov 2022
Venus Concept Inc. (NASDAQ:VERO ) Q3 2022 Earnings Conference Call November 10, 2022 5:00 PM ET Corporate Participants Rajiv De Silva - Chief Executive Officer Domenic Della Penna - Chief Financial Of
How to Make Money With Penny Stocks in a Volatile Market
11:30am, Saturday, 03'rd Sep 2022
Which strategies are you using to trade penny stocks right now? The post How to Make Money With Penny Stocks in a Volatile Market appeared first on Penny Stocks to Buy, Picks, News and Information | P
Venus Concept Inc. (VERO) CEO Dom Serafino on Q2 2022 Results - Earnings Call Transcript
02:51pm, Friday, 12'th Aug 2022
Venus Concept Inc. (NASDAQ:VERO ) Q2 2022 Earnings Conference Call August 12, 2022 4:30 PM ET Company Participants Dom Serafino - CEO Domenic Penna - CFO Ross Portaro - President of Global Sales Confe
Venus Concept (VERO) Reports Q2 Loss, Misses Revenue Estimates
09:47am, Friday, 12'th Aug 2022
Venus Concept (VERO) delivered earnings and revenue surprises of -100% and 9.11%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Venus Concept to Release Second Quarter of Fiscal Year 2022 Financial Results on August 12, 2022
07:30am, Thursday, 30'th Jun 2022
TORONTO, June 30, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that second quart
Venus Concept Inc. (VERO) CEO Dom Serafino on Q1 2022 Results - Earnings Call Transcript
09:33pm, Thursday, 12'th May 2022
Venus Concept Inc. (NASDAQ:VERO ) Q1 2022 Earnings Conference Call May 12, 2022 5:00 PM ET Company Participants Dom Serafino - CEO Domenic Penna - CFO Ross Portaro - President of Global Sales Conferen
Venus Concept (VERO) Reports Q1 Loss, Misses Revenue Estimates
07:34pm, Thursday, 12'th May 2022
Venus Concept (VERO) delivered earnings and revenue surprises of -30% and 2.20%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Venus Concept to Release First Quarter of Fiscal Year 2022 Financial Results on May 12, 2022
04:05pm, Monday, 04'th Apr 2022
TORONTO, April 04, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that first quart
Venus Concept Inc. (VERO) CEO Dom Serafino on Q4 2021 Results - Earnings Call Transcript
02:42pm, Monday, 28'th Mar 2022
Venus Concept Inc. (VERO) CEO Dom Serafino on Q4 2021 Results - Earnings Call Transcript
Venus Concept (VERO) Reports Q4 Loss, Tops Revenue Estimates
09:47am, Monday, 28'th Mar 2022
Venus Concept (VERO) delivered earnings and revenue surprises of 33.33% and 0.41%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Venus Concept Inc. to Present at the Maxim Virtual Growth Conference on March 28th
04:05pm, Monday, 21'st Mar 2022
TORONTO, March 21, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that managemen
Venus Concept to Release Fourth Quarter and Fiscal Year 2021 Financial Results on March 28, 2022
07:30am, Wednesday, 02'nd Feb 2022
TORONTO, Feb. 02, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that fourth quart
Venus Concept gets FDA nod to market BlissMAX device
01:31pm, Wednesday, 19'th Jan 2022 Seeking Alpha
Venus Concept (VERO) has won FDA 510(k) clearance to market its Venus BlissMAX device in the U.S.BlissMAX is a medical aesthetic platform that serves as a comprehensive solution for